497
Views
4
CrossRef citations to date
0
Altmetric
Articles

The therapeutic advantage of combination antihypertensive drug therapy using amlodipine and irbesartan in hypertensive patients: Analysis of the post-marketing survey data from PARTNER (Practical combination therapy of Amlodin and angiotensin II Receptor blocker; safety and efficacy in patients with hypertension) study

, , , , , & show all
Pages 542-550 | Received 29 Oct 2014, Accepted 29 Jan 2015, Published online: 15 May 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Di Zhang, Qi-Fang Huang, Chang-Sheng Sheng, Yan Li & Ji-Guang Wang. (2021) Serum uric acid change in relation to antihypertensive therapy with the dihydropyridine calcium channel blockers. Blood Pressure 30:6, pages 395-402.
Read now

Articles from other publishers (3)

Elie Chammas. (2022) Management of hypertension with fixed-dose combination of irbesartan and amlodipine: A real-life observation. Medicina Clínica Práctica 5:1, pages 100258.
Crossref
Di Zhang, Qi-Fang Huang, Yan Li & Ji-Guang Wang. (2021) Incident hyperuricemia in relation to antihypertensive therapy with the irbesartan/hydrochlorothiazide combination. Blood Pressure Monitoring 26:6, pages 413-418.
Crossref
Barbara Nieradko-Iwanicka. (2018) What is the role of angiotensin receptor blockers in treatment of hyperuricemia coexisting with arterial hypertension?. Rheumatology 56:2, pages 106-110.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.